Pavel Koranda
About
In The Last Decade
Pavel Koranda
52 papers receiving 363 citations
Peers
Comparison fields: 5 of 65
- Surgery 132
- Radiology, Nuclear Medicine and Imaging 111
- Oncology 99
- Pulmonary and Respiratory Medicine 61
- Cancer Research 57
Countries citing papers authored by Pavel Koranda
This map shows the geographic impact of Pavel Koranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Koranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Koranda more than expected).
Fields of papers citing papers by Pavel Koranda
This network shows the impact of papers produced by Pavel Koranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Koranda. The network helps show where Pavel Koranda may publish in the future.
Co-authorship network of co-authors of Pavel Koranda
This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Koranda. A scholar is included among the top collaborators of Pavel Koranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Koranda. Pavel Koranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 18-F cholin PET CT v primodiagnostice karcinomu prostaty | 2 |
| 4 | 2 | |
| 5 | 6 | |
| 6 | Correlation of Technetium Tc99m trofolastat chloride (MIP-1404) uptake using SPECT/CT with histopathology: A phase 2 study of prostate cancer (PCa) patients undergoing radical prostatectomy (RP) with extended lymph node dissection (ePLND) | 2 |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 6 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 4 | |
| 15 | 27 | |
| 16 | 12 | |
| 17 | Laboratorní diagnostika onemocnění štítné žlázy | 0 |
| 18 | 13 | |
| 19 | 9 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.